Press Release

Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025

BusinessWire

May 13, 2025

SAIL-0804 shows rapid and deep B cell depletion along with repopulation by mostly immature phenotypes in preclinical models, supporting its advancement into IND-enabling studies

Read the Release

All News & Press

Press Release

Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board

Business Wire

April 2, 2024

All News & Press

Press Release

Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines

Business Wire

January 5, 2024

All News & Press

Press Release

Sail Biomedicines Appoints Tech and Pharma Industry Veteran Frank D’Amelio to Its Board

Business Wire

January 4, 2024

All News & Press

Press Release

Sail Biomedicines Receives Grants to Fight Malaria by Developing a New Class of RNA Medicines

Business Wire

January 3, 2024

All News & Press

Press Release

Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to form Sail Biomedicines

Flagship Pioneering

October 19, 2023